American Diversified Holdings unit GlucoGuard publishes investor deck for FDA research funding
Bitget2026/09/23 13:00- American Diversified Holdings published a GlucoGuard investor deck focused on funding research required for FDA approval.
- Deck posted at https://pr.report/qnho via the DECK tab on GlucoGuardSleep.com; password “Admin123”.
- Presentation outlines capital-raising talks with institutional investors; financing expected to accelerate development, with a spinoff included in negotiations.
- Deck highlights a revised Dexcom Level 2 app integration, including an emulator-ready app and a hypoglycemia prediction algorithm with 95% accuracy.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Silver Price Forecast: XAG/USD trades flat around $53 ahead of US inflation data
Swiss Franc holds ground as US Dollar consolidates ahead of CPI inflation data

Net profit surges fivefold but masks decline in core business; crypto mining companies' shift to AI poses hidden risks
Marathon Holdings' Q3 net profit reached $632 million, up 413% year-on-year. However, its mining revenue declined by 35%. The company relied on selling 13,500 BTC to pay off debts and is now betting on AI infrastructure, increasing the risk of an imbalanced profit structure.
Lithium-For-Earth Raises KRW 1.32 Billion in Private Placement